News | June 12, 2013

Patients and Technologists Benefit from Image Reconstruction Software

UltraSPECT partnership with PharmaLogic results in quick success with hospitals

Image Reconstruction Software

June 12, 2013 — UltraSPECT, a provider of nuclear medicine (NM) image reconstruction technology that reduces radiopharmaceutical dose and acquisition time, announced the installation of its proprietary Wide Beam Reconstruction (WBR) software at nearly 10 healthcare facilities. The installations came as a result of the recent agreement between UltraSPECT and radiopharmaceutical provider PharmaLogic, under which PharmaLogic offers the WBR software as part of its patient-centered approach.

WBR addresses concerns about patient radiation exposure and improved image quality. It enhances the performance of existing NM cameras, enabling a 50 percent reduction in ASNC-recommended radiopharmaceutical injected dose, reducing imaging scan time up to 50 percent while maintaining the full level of image quality. The technology, sold as part of the UltraSPECT Xpress.Cardiac, Xpress3.Cardiac and Xpress.Bone products, can be utilized with most major manufacturers’ NM systems, as well as all clinical software packages. 

"The industry’s growing interest to reduce radiation exposure to patients and to the technologists performing the exams led us to look for a cost-effective, low-dose solution, resulting in our incredibly successful partnership with UltraSPECT,” said Steve Chilinski, president and CEO of PharmaLogic. “We believe these initial installations are just the start of a growing demand for the solution as all of our nuclear medicine customers see that everyone from patients and technologists to physicians, pharmacies and pharmacy staff will benefit.”

UltraSPECT is the only company to offer the proprietary software solution — approved by the U.S. Food and Drug Administration (FDA) — that can be retrofit into existing SPECT (single-photon emission computed tomography) imaging systems. The UltraSPECT Xpress line of products can be readily installed on current gamma camera systems. Utilizing the proprietary WBR iterative reconstruction algorithm, which simultaneously addresses resolution recovery and noise reduction for low-count density, it provides high image resolution for greater lesion localization, raising diagnostic confidence and precision. The products minimize radiation exposure for both patients and technologists, while abbreviated acquisition times reduce the possibility of patient motion artifacts and enhance patient throughput and comfort. For many WBR users, the result is enhanced equipment utilization, revenues, patient satisfaction and referrals.

Huntington Internal Medicine Group (HIMG), Huntington, W.Va., recently selected the UltraSPECT Xpress.Cardiac and Xpress.Bone solutions as part of their partnership with PharmaLogic. "When we learned about UltraSPECT’s WBR technology, we knew immediately that we needed it, and the results have been even better than what we had expected,” said Juanita Dempsey, cardiology and radiology manager at HIMG. “Not only does the ability of the software to enable half of the radioactive dose help protect our patients, but it’s greatly protecting our technologists who are overseeing the procedures again and again."

UltraSPECT is highlighting its WBR software at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), being held in June 9-12 in Vancouver, British Columbia.

For more information: www.ultraspect.com

Related Content

United Imaging Announces First U.S. Clinical Install of uMI 550 Digital PET/CT System
News | PET-CT | June 19, 2019
United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
BGN Technologies Introduces Novel Medical Imaging Radioisotope Production Method
News | Radiopharmaceuticals and Tracers | June 05, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel method for...
Applications Open for ASRT Foundation and Canon Medical's Safety FiRsT Grant Program
News | Radiation Dose Management | May 31, 2019
The ASRT Foundation and Canon Medical Systems are now accepting applications for the 2019 Safety FiRsT grant program,...
Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
ControlRad Announces FDA Clearance and Launch of ControlRad Trace
Technology | Radiation Dose Management | May 23, 2019
ControlRad Inc. announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its ControlRad...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

Image courtesy of Amen Clinics

News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor
Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S...